Lung cancer (both NSCLC and SCLC)
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: . Age > 18 years . WHO PS 0-2 . Stage IIIA/IIIB Non Small Cell Lung Cancer (NSCLC). Planned for conventionally fractionated radiotherapy with or without concomitant chemotherapy, 51-60 Gy. . Limited disease Small Cell Lung Cancer, i.e. tumor confined to hemithorax without evidence of distant metastases or malignant pleural effusion. Planned for conventionally fractionated (chemo)radiotherapy, 45 Gy. . Adequate pulmonary function . Life expectancy of at least 6 months .. Before patient registration, informed consent must be given
Exclusion criteria
Exclusion criteria: . WHO PS=3 . Life expectancy less than 6 months
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| . The regional dependency of structural lung damage (tumor location) . The relationship between lung density changes and dose distribution . The dynamics of structural lung damage (density changes) in time | — |
Primary
| Measure | Time frame |
|---|---|
| Density changes measured with serial CT-scans scored using the newly developed quantification method. | — |
Countries
Netherlands